VCS
PFE icon

Vaughan & Co Securities’s Pfizer PFE Stock Holding History

Vaughan & Co Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Sell
14,258
-1,153
-7% -$30.2K 0.16% 49
2026
Q1 		$433K Sell
15,411
-433
-3% -$11.5K 0.22% 46
2025
Q4 		$395K Sell
15,844
-495
-3% -$12.5K 0.2% 45
2025
Q3 		$416K Sell
16,339
-10,453
-39% -$258K 0.22% 46
2025
Q2 		$649K Sell
26,792
-74
-0.3% -$1.73K 0.37% 32
2025
Q1 		$681K Hold
26,866
– – 0.42% 33
2024
Q4 		$713K Sell
26,866
-289
-1% -$7.84K 0.43% 31
2024
Q3 		$786K Sell
27,155
-415
-2% -$12.1K 0.46% 28
2024
Q2 		$771K Buy
27,570
+8,370
+44% +$230K 0.49% 21
2024
Q1 		$533K Sell
19,200
-1,718
-8% -$47.7K 0.34% 44
2023
Q4 		$602K Buy
20,918
+8,480
+68% +$256K 0.4% 41
2023
Q3 		$413K Hold
12,438
– – 0.31% 46
2023
Q2 		$456K Hold
12,438
– – 0.32% 47
2023
Q1 		$507K Buy
12,438
+381
+3% +$16.5K 0.38% 46
2022
Q4 		$618K Sell
12,057
-298
-2% -$14.3K 0.49% 36
2022
Q3 		$541K Sell
12,355
-48
-0.4% -$2.33K 0.47% 37
2022
Q2 		$650K Hold
12,403
– – 0.52% 32
2022
Q1 		$642K Sell
12,403
-446
-3% -$23.1K 0.44% 38
2021
Q4 		$759K Sell
12,849
-336
-3% -$16.6K 0.51% 23
2021
Q3 		$567K Sell
13,185
-211
-2% -$9.35K 0.42% 37
2021
Q2 		$525K Hold
13,396
– – 0.39% 38
2021
Q1 		$485K Hold
13,396
– – 0.39% 39
2020
Q4 		$493K Sell
13,396
-1,072
-7% -$39.3K 0.44% 26
2020
Q3 		$504K Sell
14,468
-483
-3% -$16.9K 0.53% 22
2020
Q2 		$464K Hold
14,951
– – 0.51% 28
2020
Q1 		$463K Hold
14,951
– – 0.59% 21
2019
Q4 		$556K Buy
+14,951
New +$533K 0.5% 34

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vaughan & Co Securities's PFE Position: Q2 2026 in Review

Vaughan & Co Securities reduced its Pfizer (PFE) stake by 7.5% in Q2 2026, selling an estimated $30.2K and leaving 14,258 shares worth $343K. The position accounts for 0.16% of the portfolio, ranked #49.

Vaughan & Co Securities first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $786K in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vaughan & Co Securities held 14,258 shares of Pfizer worth $343K as of Q2 2026.
  • Vaughan & Co Securities sold 1,153 Pfizer shares in Q2 2026, an estimated $30.2K.
  • Pfizer made up 0.16% of Vaughan & Co Securities's portfolio in Q2 2026, its #49 holding.
  • Vaughan & Co Securities first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Vaughan & Co Securities's Pfizer position peaked at $786K in Q3 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vaughan & Co Securities's 13F filing for Q2 2026, filed 3 Aug 2026.